Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.72)
# 3,394
Out of 5,154 analysts
205
Total ratings
22.38%
Success rate
-7.12%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $0.97 | +827.07% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.79 | +11,073.18% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.94 | +284.62% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.16 | +244.83% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.03 | -1.48% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.08 | +9,515.38% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.70 | +1,017.65% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $6.52 | +222.09% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.11 | +1,251.35% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $1.70 | +32,841.18% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $1.95 | +6,069.67% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.96 | +571.14% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.14 | +2,531.58% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.98 | +90.38% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.78 | +475.54% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.77 | +681.66% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.84 | +11,874.61% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $4.55 | +1,186,713.19% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.52 | +693.65% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.36 | +468,650.00% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $9.13 | +5,376.45% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $35.22 | +581.43% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.81 | +9,837.89% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $10.69 | +74,736.30% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.53 | +357.52% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.64 | +1,729.27% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.27 | +836.77% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.94 | +356.85% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.10 | +61.29% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $60.41 | -60.27% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.66 | +518,081.82% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $0.92 | +2,065,117.39% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $0.97
Upside: +827.07%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.79
Upside: +11,073.18%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.94
Upside: +284.62%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.16
Upside: +244.83%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.03
Upside: -1.48%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.08
Upside: +9,515.38%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $1.70
Upside: +1,017.65%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $6.52
Upside: +222.09%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.11
Upside: +1,251.35%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $1.70
Upside: +32,841.18%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $1.95
Upside: +6,069.67%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $5.96
Upside: +571.14%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.14
Upside: +2,531.58%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $9.98
Upside: +90.38%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.78
Upside: +475.54%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.77
Upside: +681.66%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.84
Upside: +11,874.61%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $4.55
Upside: +1,186,713.19%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.52
Upside: +693.65%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.36
Upside: +468,650.00%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $9.13
Upside: +5,376.45%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $35.22
Upside: +581.43%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.81
Upside: +9,837.89%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $10.69
Upside: +74,736.30%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.53
Upside: +357.52%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.64
Upside: +1,729.27%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.27
Upside: +836.77%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $3.94
Upside: +356.85%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $3.10
Upside: +61.29%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $60.41
Upside: -60.27%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.66
Upside: +518,081.82%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $0.92
Upside: +2,065,117.39%